TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/25 16:01 | 2/18/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | P | 167 | 6.67 | 0 | 25 | 1 | 1,938 | D | ||||||||||||||
12/4/24 21:03 | 12/3/24 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | P.m | 718 | 10.26 | 0 | 70 | 4 | 1,913 | D | ||||||||||||||
11/20/24 17:20 | 11/18/24 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | P.m | 149 | 14.89 | 0 | 10 | 1 | 1,843 | D | ||||||||||||||
9/20/24 18:34 | 9/18/24 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | P.m | 361 | 18.04 | 0 | 20 | 1 | 1,833 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |